Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects to growth to accelerate.
Pfizer Inc. shares fell 1.6% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
